Search by Drug Name or NDC

NDC 00113-0432-62 Good Sense Nasal Decongestant 30 mg/1 Details

Good Sense Nasal Decongestant 30 mg/1

Good Sense Nasal Decongestant is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by L. Perrigo Company. The primary component is PSEUDOEPHEDRINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.

Related Packages: 00113-0432-62
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pseudoephedrine

Product Information

NDC	00113-0432
Product ID	0113-0432_44b5fcf0-1cc1-48be-804b-b732482d5caa
Associated GPIs	42101020100305
GCN Sequence Number	005089
GCN Sequence Number Description	pseudoephedrine HCl TABLET 30 MG ORAL
HIC3	B6V
HIC3 Description	DECONGESTANTS, ORAL
GCN	20481
HICL Sequence Number	002091
HICL Sequence Number Description	PSEUDOEPHEDRINE HCL
Brand/Generic	Generic
Proprietary Name	Good Sense Nasal Decongestant
Proprietary Name Suffix	n/a
Non-Proprietary Name	Pseudoephedrine HCl
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	30
Active Ingredient Units	mg/1
Substance Name	PSEUDOEPHEDRINE HYDROCHLORIDE
Labeler Name	L. Perrigo Company
Pharmaceutical Class	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
DEA Schedule	n/a
Marketing Category	OTC MONOGRAPH FINAL
Application Number	part341
Listing Certified Through	2024-12-31

Package

Package Images

NDC 00113-0432-62 (00113043262)

Pricing Information
NDC Package Code	0113-0432-62
Billing NDC	00113043262
Package	1 BLISTER PACK in 1 CARTON (0113-0432-62) / 24 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date	1989-09-15
NDC Exclude Flag	N
Price Per Unit	0.05727
Pricing Unit	EA
Effective Date	2024-02-21
NDC Description	GS NASAL DECONGEST 30 MG TAB
Pharmacy Type Indicator	C/I
OTC	Y
Explanation Code	1
Classification for Rate Setting	G
As of Date	2024-02-21

This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

Standard Product Labeling (SPL)/Prescribing Information SPL 455b35b4-3969-411b-8036-887615d71e11 Details

Active ingredient (in each tablet)

Pseudoephedrine HCl 30 mg

Purpose

Nasal decongestant

Uses

•: temporarily relieves sinus congestion and pressure
•: temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies

Warnings

Do not use

if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

•: heart disease
•: high blood pressure
•: thyroid disease
•: diabetes
•: trouble urinating due to an enlarged prostate gland

When using this product

do not exceed recommended dosage

Stop use and ask a doctor if

•: nervousness, dizziness, or sleeplessness occur
•: symptoms do not improve within 7 days or occur with fever

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

adults and children 12 years and over	• take 2 tablets every 4 to 6 hours • do not take more than 8 tablets in 24 hours
children ages 6 to 11 years	• take 1 tablet every 4 to 6 hours • do not take more than 4 tablets in 24 hours
children under 6 years	do not use this product in children under 6 years of age

Other information

•: each tablet contains: calcium 20 mg
•: store at 20°-25°C (68°-77°F)
•: do not use if blister unit is broken or torn

Inactive ingredients

carnauba wax, dibasic calcium phosphate dihydrate, FD&C red no. 40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, silicon dioxide, titanium dioxide

Questions or comments?

1-800-719-9260

Principal Display Panel

Maximum Strength

Congestion

Non-Drowsy

Nasal Decongestant

Actual Size

Pseudoephedrine HCl Tablets

Nasal Decongestant

Nasal & Sinus Congestion

Sinus Pressure

Compare to active ingredient of Sudafed® Congestion Tablets

24 Tablets (30 mg Each)

INGREDIENTS AND APPEARANCE

GOOD SENSE NASAL DECONGESTANT

pseudoephedrine hcl tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0113-0432
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F)	PSEUDOEPHEDRINE HYDROCHLORIDE	30 mg

Ingredient Name	Strength
Inactive Ingredients
CARNAUBA WAX (UNII: R12CBM0EIZ)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POLYSORBATE 80 (UNII: 6OZP39ZG8H)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
FD&C RED NO. 40 (UNII: WZB9127XOA)

Product Characteristics
Color	RED	Score	no score
Shape	ROUND (convex)	Size	7mm
Flavor		Imprint Code	L432
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:0113-0432-62	1 in 1 CARTON	09/15/1989
1		24 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph final	part341	09/15/1989

Labeler - L. Perrigo Company (006013346)

Revised: 12/2019

Document Id: 44b5fcf0-1cc1-48be-804b-b732482d5caa

Set id: 455b35b4-3969-411b-8036-887615d71e11

Version: 3

Effective Time: 20191210